You have searched for "Drug Control Authority"
Showing 1-10 of 17
KUALA LUMPUR: Shares of Duopharma Biotech Bhd were lacklustre in the morning session on Thursday, falling to a low of RM2.64 – the lowest since April 26.
KUALA LUMPUR: CGS-CIMB Equities Research is retaining its Add call for Duopharma Biotech with an unchanged target price of RM3.67 due to the potential long-term earnings prospects from the development of vaccine manufacturing capabilities, which is a key rerating catalyst.
Duopharma Biotech Bhd has concluded the supply agreements with the Malaysian government and Russian Direct Investment Fund (RDIF) for the supply of 6.4 million doses of the Sputnik V vaccine.
Duopharma Biotech Bhd has concluded the supply agreements with the Malaysian Government and Russian Direct Investment Fund (RDIF) for the supply of 6.4 million doses of the Sputnik V vaccine.
CGS-CIMB Equities Research has upgraded its recommendation for Duopharma Biotech to an add from hold and kept its target price at RM3.67, which is 25.2% above the last closing price of RM2.93.
KUALA LUMPUR: Duopharma Biotech Bhd said earnings climbed in the first quarter of stronger demand for healthcare products.
PETALING JAYA: Technology firm Solution Group Bhd’s unit Solution Biologics Sdn Bhd (Solbio) said it has signed a term sheet agreement with the Health Ministry to supply Covid-19 vaccines to the government.
KUALA LUMPUR: Solution Group Bhd said wholly-owned subsidiary Solution Biologics Sdn Bhd (SolBio) has signed a term sheet agreement with the Ministry of Health (MoH) for the supply of Covid-19 vaccine to the government.
THE Federation of Malaysian Manufacturers (FMM) told its members on Monday to take additional measures and tighten the standard operating procedures (SOPs) at their workplace and living quarters of employees to curb the spread of the Covid-19.
KUALA LUMPUR: Shares of Pharmaniga Bhd and Duopharma Biotech Bhd climbed in active trade on Wednesday as the companies sign agreement with the Government to supply Covid-19 vaccine.